Betahistine
Antivertigo Preparations
Sold as SERC-8 · SERC-16
- Drug class
- Antivertigo Preparations
- Availability
- See label
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 53
Overview
Betahistine is an active pharmaceutical ingredient in the Antivertigo Preparations group (N07CA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 47 | May 1, 2026 |
| CA Canada | Health Canada | 6 | June 18, 2025 |
GBUnited Kingdom· MHRA
47 products
Uses
Vertigo, tinnitus and hearing loss associated with Ménière's syndrome.
How to take
CACanada· Health Canada
6 products
Uses
AND CLINICAL USE ............................................................................. 3 CONTRAINDICATIONS .................................................................................................. 3 WARNINGS AND PRECAUTIONS .................................................................................
4 ADVERSE REACTIONS................................................................................................... 4 DRUG INTERACTIONS ...................................................................................................
6 DOSAGE AND ADMINISTRATION ............................................................................... 6 OVERDOSAGE .................................................................................................................
7 ACTION AND CLINICAL PHARMACOLOGY ............................................................. 7 STORAGE AND STABILITY ......................................................................................... 10 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................................
Sources & citations
- [1]MHRA (UK) · PL306840299 · revised April 24, 2026
- [2]Health Canada (DPD) · 02466449 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.